Guidelines endorsed by RCPCH - Emergency medicine

The College reviews high quality guidelines and standards produced and published by other organisations against the RCPCH Standards for Endorsement.

The following have been endorsed or supported by the College:

Endorsed guidelines

Paediatrics Allergy Action Care Plans (BSAC)

The plans have been designed to facilitate first aid treatment of anaphylaxis, to be delivered by people without any special medical training or equipment apart from access to an adrenaline auto injector (AAI). They may also be used to provide a framework for management of anaphylactic reactions to health professionals who are less familiar with this aspect of clinical care.

Date of Publication: September 2013
Date of Endorsement: October 2013

Personal plan for individuals prescribed EpiPen (PDF, 324KB, 1 Page)
A generic plans for individuals assessed as not needing AAI (PDF, 188KB, 1 Page)
Personal plans for individuals prescribed Jext (PDF, 188KB, 1 Page)
 

Bacterial Meningitis and Meningococcal Septicaemia in Children (NICE)

This NICE quality standard defines clinical best practice within this topic area. It provides specific, concise quality statements, measures and audience descriptors to provide the public, health and social care professionals, commissioners and service providers with definitions of high-quality care.

This quality standard covers the diagnosis and management of children and young people (younger than 16 years) with bacterial meningitis or meningococcal septicaemia.

Date of Publication: June 2012
Date of Endorsement: July 2012

Full quality standard (PDF, 257KB, 50 Pages)
 

Abusive Head Trauma and the Eye in Infancy (RCOphth-RCPCH)

This guidance update is a joint venture between the Royal College of Ophthalmologists (RCOphth) and the Royal College of Paediatricians and Child Health (RCPCH). The update is restricted to a target population of children under 3 years of age suspected of being subject to abusive head trauma (AHT).

This guidance covers a review of the existing literature on AHT and the eye to supplement and update previous publications produced by RCO. This guidance also identifies areas of good practice in the management of cases referred with suspected AHT and encourage evidence based standardized assessment of such children. The guidance includes a standardised proforma for documenting retinal findings.

Date of Publication: June 2013
Date of Endorsement: June 2013

Full guidance (PDF, 1408KB, 106 Pages)
Standardised proforma (PDF, 748KB, 2 Pages)
 

Good Practice in Postoperative and Procedural Pain Management (APA)

 It is intended that this guideline will be used by practitioners involved in the acute care of children undergoing pain management after surgery or for painful medical procedures. The guideline is designed to provide evidence-based information on the efficacy of analgesic strategies such that an informed choice of analgesics that are appropriate for the patient and clinical setting can be made. The document includes advice on the assessment of pain and a summary of current evidence for the efficacy of analgesic strategies, including evidence-based recommendations which have been graded using the SIGN criteria and grouped according to named procedures. It is an update of the guideline published in 2008.

Date of Publication: July 2012
Date of Endorsement: July 2012

Full guideline (PDF, 731KB, 81 Pages)
 

Alcohol Use Disorders: Physical Complications (NICE)

This guideline covers the management of acute alcohol withdrawal, lack of thiamine, liver disease and inflammation of the pancreas in adults and young people over the age of 10 years.

The guideline is accompanied by a quick reference guide, algorithm, baseline assessment tool, costing template, audit support, costing report and a slide set.

Date of Publication: June 2010
Date of Endorsement: September 2010

Full guideline (PDF, 2.97MB, 295)
NICE guideline (PDF, 471KB, 30)
 

Allergy Care Pathways (RCPCH)

The RCPCH has developed care pathways for children with allergic conditions following the Department of Health publication on the "Review of allergy services" (2006).  These can be dowloaded below.

  • Anaphylaxis
  • Food allergy
  • Asthma/Rhinitis
  • Eczema
  • Urticaria/Mastocytosis/Angio-oedema
  • Drug allergy
  • Venom allergy
  • Latex allergy

Further information including leaflets and videos for families can be found here:

www.rcpch.ac.uk/allergy
 

Anaphylaxis (NICE)

This guideline concerns assessment with a view to confirming an anaphylactic episode and the decision to refer after emergency treatment for a suspected anaphylactic episode. The patient groups covered by the guideline are adults, young people and children who receive emergency treatment for suspected anaphylaxis.

RCPCH notes:

The College asks members to note that:

The scope of the guideline covers confirmation of an anaphylactic reaction in an emergency setting and subsequent referral. As such the scope is quite narrow and excludes longer-term management of children who have experienced an anaphylactic episode (e.g. management through diet). Management of associated co-morbidities with anaphylaxis, such as asthma are also not included in the scope of the guideline. NICE however do refer readers to their related Food Allergy in Children and Young People guideline for information on allergy diagnosis and assessment. 

Date of Publication: December 2011
Date of Endorsement: March 2012

NICE guideline (PDF, 164KB, 25 Pages)
Appendices
 

British Guideline on the Management of Asthma (2009 Update) (SIGN/BTS)

This guideline covers the management of asthma in adults and children. The 2009 Update includes updated sections on pharmacological management, the management of acute asthma and asthma in pregnancy.

The guideline is accompanied by algorithms covering the management of children in general practice, emergency departments and hospital and includes a template of a personal asthma action plan, case studies, educational studies and equality impact assessment tools.

RCPCH notes:

The RCPCH welcomes the publication of this guideline but asks Members to note the following:

  • The guideline does not offer advice on steroid replacement dosage in the event of severe inter-current illness as part of a management plan if the child is being maintained on doses known to be associated with a risk of adrenal insufficiency.
  • The following recommendation is based on expert opinion: 'Children aged <3 years are likely to require a face mask connected to the mouthpiece of a spacer for successful drug delivery'.

Date of Publication: April 2009
Date of Endorsement: June 2010

Full Guideline (PDF, 2.06MB, 132 Pages)
Quick Reference Guide (PDF, 1.23MB, 26 Pages)
 

British Guideline on the Management of Asthma (SIGN/BTS)

This guideline covers comprehensive advice on asthma management for patients of all ages in primary and secondary care for all health professionals involved in the care of people with asthma.

The guideline is accompanied by a quick reference guide, case studies, educational slides and 'Be In Control' materials. It includes evidence tables, occupational asthma record forms and an equality impact assessment form.

RCPCH notes: 

This guideline is currently being updated and will include updated sections on pharmacological management, the management of acute asthma and asthma in pregnancy.

Date of Publication: February 2003
Date of Endorsement: February 2003
 

Bacterial Meningitis and Meningococcal Septicaemia in Children (NICE)

The guideline covers the diagnosis and management of bacterial meningitis and meningococcal septicaemia in children and young people under 16 years in primary and secondary care.

The guideline is accompanied by a quick reference guide, parent/carer version, audit tools and algorithms.

RCPCH notes:

Please note that since publication of the guideline:

'In children and young people with shock that is unresponsive to vasoactive agents, steroid replacement therapy using low-dose corticosteroids (hydrocortisone 0.25mg/m2 four times daily) should be used only when directed by a paediatric intensivist.'

To:

'In children and young people with shock that is unresponsive to vasoactive agents, steroid replacement therapy using low-dose corticosteroids (hydrocortisone 25mg/m2) four times daily) should be used only when directed by a paediatric intensivist.'

  • NICE have updated the quick reference guide to reflect the action required when meningococcal meningitis is confirmed in children older than 3 months. Please see the NICE website for further information.
  • Recommendation 1.4.45 has been amended from:

    'In children and young people with shock that is unresponsive to vasoactive agents, steroid replacement therapy using low-dose corticosteroids (hydrocortisone 0.25mg/m2 four times daily) should be used only when directed by a paediatric intensivist.'

    To:

    'In children and young people with shock that is unresponsive to vasoactive agents, steroid replacement therapy using low-dose corticosteroids (hydrocortisone 25mg/m2) four times daily) should be used only when directed by a paediatric intensivist.'

Date of Publication: June 2010
Date of Endorsement: June 2010

Full guideline (PDF, 5.75MB, 275 Pages)
NICE Guideline (Revised) (PDF, 294KB, 45 Pages)
Press Release (PDF, 47KB, 6 Pages)
 

Children Presenting with Acute Breathing Difficulties (PAERG)

The guideline aims to provide clinicians with recommendations for the management of children presenting with acute breathing difficulties based on the available evidence. It also aims to promote consistency of care of patients with similar clinical problems and to guide the decision-making process of junior doctors seeing the majority of patients in the first instance.

RCPCH notes: 

This guideline is due for review by the Paediatric Accident and Emergency Research Group.

Date of Publication: January 2002
Date of Endorsement: December 2002

Full guideline (PDF, 943KB, 112 Pages)
 

Bronchiolitis in Children (SIGN)

The guideline covers the prevention, diagnosis, investigation, treatment and management of bronchiolitis in children. It focuses on the clinically diagnosed condition of bronchiolitis in infants aged less than 12 months and also considers a specific group up to 24 months of age: those born prematurely (less than or equal to 37 weeks of gestational age) and those with congenital heart disease or underlying respiratory disease.

The guideline is accompanied by a parent leaflet, quick reference guide and includes key points for audit, research recommendations and local resource implications.

Date of Publication: November 2006
Date of Endorsement: April 2008

Full guideline (PDF, 1.79MB, 46 Pages)
Quick reference guide (PDF, 590KB, 2 Pages)
Parent information leaflet (PDF, 280KB, 2 Pages)
 

Physical Signs of Child Sexual Abuse (RCPCH)

This handbook is a revision of the 1997 RCP publication 'Physical Signs of Sexual Abuse in Children' and is based on the best available evidence. The review focuses on evidence for the physical signs of CSA in the following areas: female genitalia, male genitalia, anal signs, oral signs and sexually transmitted infections.

This was developed with The Royal College of Physicians of London and its Faculty of Forensic and Legal Medicine.

Date of Publication: April 2008
Date of Endorsement: April 2008

Further information can be found here
 

When to Suspect Child Maltreatment (NICE)

This guidance covers the clinical features (including physical and psychological symptoms) associated with maltreatment which may be observed by health professionals when a child presents to them. It is aimed at all health professionals, including GPs, primary health and child health teams, professionals groups who are routinely involved in the care of children and families and those who may encounter children in the course of their professional duties.

The guideline is accompanied by a quick reference guide, costing tools, slides highlighting the key messages, audit support tools and an educational tool.

The RCPCH welcomes the publication of this valuable and important guidance and fully endorses it. The College notes that:

  • The NICE guideline uses less technical terms which in some areas may appear to differ from RCPCH documents. This is because the intended audience of the NICE guideline is front line health professionals rather than specialist paediatricians (although the guideline is of relevance to paediatricians also).

Please note: As of December 2009, recommendation 5.8 on inappropriately explained school attendance has been amended. This recommendation has been changed from:

"Consider child maltreatment if a child has poor school attendance that the parents or carers know about that has no justification on health, including mental health, grounds and formally approved home education is not being provided."

to:

"Consider child maltreatment if a child has poor school attendance that the parents or carers know about that has no justification on health, including mental health, grounds and home education is not being provided."

Date of Publication: July 2009
Date of Endorsement: July 2009

Full guideline (PDF, 1.48MB, 156 Pages)
NICE guideline (PDF, 372KB, 39 Pages)
Key messages (PDF, 235KB, 12 Pages)
RCPCH press statement (PDF, 37KB, 1 Page)
 

Management of the Child with a Decreased Conscious Level (PAERG)

The scope of the guideline includes children aged 0-18 years who have a decreased conscious level and are being reviewed in a hospital setting. Decreased conscious level is defined as a modified Glasgow coma score less than 14, or being unresponsive only to voice or being unresponsive on the AVPU scale. The guideline does not apply to pre-term infants on a NICU or full term infants with a decreased conscious level from birth onwards. Also, the guideline does not apply to children with a previously diagnosed condition that is known to cause the decreased conscious level.

The guideline is accompanied by a quick reference algorithm, guide to implementation and audit criteria.

Date of Publication: November 2005
Date of Endorsement: October 2006

Full technical document (PDF, 594KB, 88 Pages)
Recommendations summary (PDF, 442KB, 59 Pages)
 

Constipation in Children and Young People (NICE)

This guideline covers the diagnosis and management of idiopathic constipation in children up to 18 years of age in primary and secondary care.

The guideline is accompanied by a quick reference guide, audit support, a baseline assessment tool, slide set and parent/carer version.

RCPCH notes:

The RCPCH welcomes publication of this guideline but asks Members to note:

  • Although not explicit in the NICE guideline, the College thinks that the goals of treatment should include 'no pain' and 'no overflow.
  • The guideline recommends some dosages which vary from those recommended in the British National Formulary for Children (2009 Edition). These are highlighted in the guideline. Please note that the BNF-c has been updated since publication of the guideline in 2010.

Date of Publication: June 2010
Date of Endorsement: June 2010

Full guideline (PDF, 2.55MB, 255 Pages)
 

Children Presenting to Hospital with Diarrhoea, with or without Vomiting (PAERG)

The policy is for the child presenting to an acute facility (accident and emergency or admissions/paediatric assessment unit) with acute diarrhoea (≤7days) with or without vomiting. Children presenting with vomiting alone or chronic diarrhoea (>7 days) are not considered. Further management decision over the next 6-12 hours and indications for review and discharge are also given.

This guideline is accompanied by an algorithm for use in clinical areas.

RCPCH notes: 

This guideline has been superseded by NICE Diarrhoea and Vomiting in Children Under 5 (2009).

Date of Publication: November 2002
Date of Endorsement: September 2003

Full guideline (PDF, 207KB, 32 Pages)
 

Diarrhoea and Vomiting In Children Under 5 (NICE)

This guideline covers the management of young children under 5 years of age with acute diarrhoea, with or without vomiting, due to gastroenteritis.

The guideline is accompanied by a quick reference guide, a parent/carer advice sheet to support consultations, costing tools, a slide set, audit support, and a chart to facilitate assessment of dehydration. It also includes key priorities for implementation.

The RCPCH welcomes the publication of this guideline but asks Members to note the following:

  • The guideline recommends that IV fluids should only be given if the child is in shock or is deteriorating despite ORS. It should be noted that NICE state that this recommendation has been made to prevent unnecessary IVT.
  • This guideline supersedes the Paediatric A&E Research Group guideline 'Children Presenting to Hospital with Diarrhoea, with or without Vomiting' published in 2002.

Date of Publication: April 2009
Date of Endorsement: August 2009

Full guideline (PDF, 3.18MB, 200 Pages)
NICE guideline (PDF, 1.82MB, 33 Pages)
Key Messages Presentation (PDF, 245KB, 21Pages)
 

Epilepsies in Children and Young People (SIGN)

This guideline covers the diagnosis and management of the epilepsies of children and young people aged from one month to 19 years of age remaining in secondary education. The guideline is aimed at healthcare professionals involved in the diagnosis and management of childhood epilepsy. Throughout the guideline seizures are referred - these may be epileptic or non-epileptic. Further, a convulsion or convulsive seizure refers to a specific type of seizure involving motor movements, which may also be epileptic or non-epileptic.

Date of Publication: April 2005
Date of Endorsement: May 2005

Full guideline (PDF, 973KB, 57 Pages)
Quick reference guide (PDF, 181KB, 2 Pages)
 

Epilepsies in Adults and Children in Primary and Secondary Care (NICE)

This guideline covers the diagnosis, treatment and management of epilepsy in children, adolescents and adults. It includes recommendations on children with learning difficulties, partial and generalised epilepsies, primary, secondary and tertiary settings including accident and emergency departments, the use of pharmacological and non-pharmacological interventions (including ketogenic diet) and monitoring by the clinician, patient and carer. The guideline also provides recommendations on tertiary procedures such as surgical techniques or Vagus Nerve Stimulation. The guideline does not include recommendations relating to the management of neonates or febrile convulsions, nor does it provide recommendations on driving or indications for referral to surgery.

The guideline is accompanied by a quick reference guide, an online educational tool, and a commissioning guide. It includes audit criteria and key priorities for implementation.

RCPCH notes: 

This guideline is currently being updated by NICE and is due for publication in 2010.

Date of Publication: October 2004
Date of Endorsement: January 2005

Full guideline (PDF, 1.06MB, 397 Pages)
NICE guideline (PDF, 349KB, 73 Pages)
Implementation presentation (PDF, 1.47MB, 25 Pages)
 

Feverish Illness in Children (NICE)

The guideline covers the assessment and initial management of children aged up to 5 years presenting to health services with feverish illness. It includes a traffic light system to assess children with feverish illness for the presence or absence of symptoms and signs that can be used to predict the risk of serious illness. An outline care pathway presents how a child with feverish illness might access and be managed by the health services.

The guideline is accompanied by a quick reference guide, information for parents/carers, slides highlighting the key messages, costing tools and implementation advice and includes key priorities for implementation and audit criteria.

RCPCH notes: 

RCPCH conducted a multi-method research project to understand and improve the experience of parents and carers who need advice when a child has a fever, based on this guideline. For more information, visit our Fever project page.

Date of Publication: May 2007
Date of Endorsement: March 2008

Full guideline (PDF, 1.86MB, 170 Pages)
NICE guideline (PDF, 270KB, 38 Pages)
 

Head Injury (NICE)

This guideline covers best practice advice on the care of adults, children (aged 1-15 years) and infants (under 1 year) who present with suspected or confirmed traumatic head injury with or without major trauma or who may be unaware that they have sustained a head injury because of intoxication or other causes. The age groups 'infants and young children' (i.e., <5 years), as well as cut-off points of 10 and 12 years are used.

The guideline is accompanied by a quick reference guide, costing tools and implementation advice and includes key priorities for implementation and audit criteria.

Date of Publication: September 2007
Date of Endorsement: April 2008

Full guideline (PDF, 1.21MB, 231 Pages)
NICE guideline (PDF, 340KB, 54 Pages)
Implementation presentation (PDF, 185KB, 12 Pages)
 

Management of Invasive Meningococcal Disease in Children and Young People (SIGN)

This guideline covers best practice in the recognition and management of meningococcal disease in children and young people up to 16 years of age.

The guideline is accompanied by a quick reference guide and information for parents and carers and includes key audit criteria.

The RCPCH welcomes the publication of this guideline but asks Members to note the following:

  • The recommendation that "parenteral antibiotics (either benzylpenicillin or cefotaximine) should be administered in children as soon as IMD is suspected and not delayed pending investigations" is a Grade D recommendation and based upon expert opinion. Evidence from a systematic review by Hahne et al suggested that the use of parenteral antibiotics is inconsistent and that results are inconclusive. SIGN have amended the guideline to include this reference; however, the grading has not been altered as the recommendation is in line with advice from the Health Protection Agency.

Date of Publication: May 2008
Date of Endorsement: April 2009

Full guideline (PDF, 572KB, 53 Pages)
Quick reference guide (PDF, 181KB, 2 Pages)
Key messages (PDF, 537KB, 25 Pages)
 

Organ Donation for Transplantation (NICE)

This guideline recognises the complexities that arise owing to the majority of potential adult and paediatric organ donors lacking the capacity to be directly involved in decision making at the time of their death. It covers strategies for improving donor identification and consent rates for deceased organ donation.

RCPCH notes:

The College asks members to note that:

  • There are few data on the validity of trigger tools in paediatric practice. NICE’s response to this comment is as follows: ‘The GDG made their decisions using the best available evidence, and where this was not available or lacking, the GDG based their recommendations on their clinical experience.’ It should be noted that NICE has deemed the best evidence from studies investigating conversion of patients displaying clinical triggers into organ donors is of very low quality.
  • Explicit reference to contraindications to donation from a paediatric perspective is not covered by the guideline.  This is because the GDG agreed that contraindications should not be included due to the rapid pace at which changes to contraindications occur particularly in paediatric patients.

Date of Publication: December 2011
Date of Endorsement: February 2012

Full guideline (PDF, 168KB, 28 pages)
Appendices
 

Recognition and Assessment of Acute Pain in Children (RCN)

This guideline updates the Royal College of Nursing (RCN) guideline 'Assessment of Acute Pain in Children' (2001). The guideline covers the recognition of acute pain in children, as well as the assessment of acute pain using scales and other tools in children with and without cognitive impairment. It provides recommendations based upon the best available evidence.

The guideline is accompanied by a quick reference guide and poster, and includes implementation advice.

The RCPCH believes that the update of this guideline is extremely valuable. However, the College believes that it would be worthwhile to consider cross-cultural and ethnicity issues in a future update of the guideline.

Date of Publication: September 2009
Date of Endorsement: July 2009

Full guideline (PDF, 3.06MB, 74 Pages)
 

Post-Seizure Management (PAERG)

The guideline covers the management of children presenting following afebrile or febrile seizures based on the best available evidence. It aims to promote consistency of care of patients with similar clinical problems and helps clinicians recognise those children at higher risk of meningitis and to take appropriate action and to determine the cause of the fever if febrile seizure is diagnosed.

The guideline is accompanied by an algorithm for use in clinical areas.

RCPCH notes: 

This guideline is due for review by the Paediatric Accident and Emergency Research Group.

Date of Publication: July 2002
Date of Endorsement: December 2002

Full guideline (PDF, 275KB, 123 Pages)
 

Respiratory Tract Infections (NICE)

This guideline covers the treatment of adults and children, 3 months or older, with respiratory tract infections (RTIs) for which immediate antibiotic prescribing is not indicated.

The guideline is accompanied by a quick reference guide, information for patients, slides highlighting the key messages and audit tools and includes care pathways, audit criteria and key priorities for implementation.

Date of Publication: July 2008
Date of Endorsement: January 2009

Full guideline (PDF, 629KB, 121 Pages)
NICE guideline (PDF, 141KB, 19 Pages)
Key Messages (PDF, 28.1KB, 20 Pages)
 

Sedation in Children and Young People (NICE)

This guideline covers the sedation of infants, children and young people up to the age of 19 years for diagnostic and therapeutic procedures.

The guideline is accompanied by a quick reference guide, audit support, a costing report, a baseline assessment tool and a slide set.

The RCPCH welcomes the publication of this guideline but asks Members to note the following:

  • The guideline recommends that referral to a mental health specialist should be considered for all children who are severely anxious or who have a learning disability undergoing an elective procedure. The College notes that this may significantly increase the waiting times for procedures, given the existing pressures upon mental health services.

Date of Publication: November 2010
Date of Endorsement: January 2011

NICE guideline (PDF, 219KB, 37 Pages)
 

Self-Harm: Longer-Term Management (NICE)

This guideline is concerned with the longer-term psychological treatment and management of both single and recurrent episodes of self-harm. It does not cover recommendations for the physical treatment of self-harm or for psychosocial management in emergency departments (these can be found in NICE clinical guideline 16 which covers treatment of self-harm within 48 hours of an incident). The term self-harm used in this guideline refers to any act of self-poisoning or self-injury.

Date of Publication: November 2011
Date of Endorsement: February 2012

NICE guideline (PDF, 212KB, 40 Pages)
Appendices

Self-Harm: Short-Term Physical and Psychological Management and Secondary Prevention (NICE)

This guideline covers the short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care. It covers all children aged 8 years and older, young people and adults who have carried out self-harm, regardless of whether accompanied by mental illness. The guideline makes recommendations that cover the first 48 hours following an act of self-harm but does not address long-term psychiatric care.

The guideline is accompanied by key recommendations for implementation.

Date of Publication: July 2004
Date of Endorsement: February 2005

Full guideline (PDF, 584KB, 200 Pages)
NICE guideline (PDF, 121KB, 49 Pages)
 

Urinary Tract Infection in Febrile Infants and Young Children (AAP)

The aim of the guideline was to formulate recommendations for health care professionals about the diagnosis, treatment, and evaluation of an initial urinary tract infection (UTI) in febrile infants and young children ages 2 months to 2 years.

The guideline includes an algorithm.

RCPCH notes: 

This guideline will be updated in 2009 by the American Academy of Pediatrics.

Date of Publication: April 1999
Date of Endorsement: April 1999

Technical report (PDF, 990KB, 60 Pages)
 

Urinary Tract Infection in Children (NICE)

The guideline covers the investigations and treatment for children younger than 16 years who have a urinary tract infection (UTI) and the information that should be offered to their families. Urine testing strategies are provided. The guideline is particularly relevant to all healthcare professionals who are involved in providing care for children who have a UTI, those responsible for commissioning and planning healthcare services and children who have a UTI and their families.

The guideline includes key priorities for implementation, a quick reference guide, information for parents/carers, slides highlighting the key messages, audit criteria, costing tools, implementation advice, and an online educational tool.

Date of Publication: August 2007
Date of Endorsement: March 2008

Full guideline (PDF, 5.56MB, 178 Pages)
NICE guideline (PDF, 252KB, 30 Pages)

 

Supported guidelines

Surgical Site Infection (NICE)

This guideline covers the prevention and treatment of surgical site infection in adults and children undergoing surgical incisions through the skin, including minimal invasive surgery.

The guideline is accompanied by a costing report, slide set, quick reference guide, parent/carer version and audit support and includes audit criteria.

The RCPCH welcomes the publication of this guideline but asks Members to note the following:

  • The guideline presents recommendations relating to the prevention and treatment of surgical site infection, however the Guideline Development Group did not include paediatric representation.

Date of Publication: October 2008
Date of College Support: September 2009

Full guideline (PDF, 5.9 MB, 168 Pages)
NICE guideline (PDF, 213 KB, 28 Pages)
 

Late intrauterine fetal death and stillbirth (RCOG)

This guideline identifies evidence-based options for women (and their relatives) who have a late intrauterine fetal death (IUFD: after 24 completed weeks of pregnancy) of a singleton fetus. It includes information on general care before, during and after birth, and care in future pregnancies.

Date of publication: October 2010
Date of College support: 2011

Full guideline (PDF, 460KB, 33 Pages)